Back
Zevra Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49
ZVRA
Zevra Therapeutics, Inc.
Last Price:
$8.97
Seasonality Move:
0.44%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Zevra Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.69 | Buy |
| 20-day SMA: | 8.53 | Buy |
| 50-day SMA: | 9.14 | Sell |
| 200-day SMA: | 9.15 | Sell |
| 8-day EMA: | 8.04 | Buy |
| 20-day EMA: | 5.47 | Buy |
| 50-day EMA: | 2.84 | Buy |
| 200-day EMA: | 0.82 | Buy |
Zevra Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.43 | Buy |
| Relative Strength Index (14 RSI): | 56.49 | Buy |
| Chaikin Money Flow: | 740579 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.25 - 8.75) | Buy |
| Bollinger Bands (100): | (8.22 - 10.3) | Sell |
Zevra Therapeutics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Zevra Therapeutics, Inc. Stock
Is Zevra Therapeutics, Inc. Stock a Buy?
-
Zevra Therapeutics, Inc. share price is 8.96 while ZVRA 8-day simple moving average is 8.69, which is a Buy signal.
-
The stock price of ZVRA is 8.96 while Zevra Therapeutics, Inc. 20-day SMA is 8.53, which makes it a Buy.
-
Zevra Therapeutics, Inc. 50-day simple moving average is 9.14 while ZVRA share price is 8.96, making it a Sell technically.
-
ZVRA stock price is 8.96 and Zevra Therapeutics, Inc. 200-day simple moving average is 9.15, creating a Sell signal.
ZVRA Technical Analysis vs Fundamental Analysis
Sell
49
Zevra Therapeutics, Inc. (ZVRA)
is a Sell
Is Zevra Therapeutics, Inc. a Buy or a Sell?
-
Zevra Therapeutics, Inc. stock is rated a SellThe current Zevra Therapeutics, Inc. [ZVRA] share price is $8.96. The Score for ZVRA is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
Zevra Therapeutics, Inc. Stock Info
Market Cap:
504.4M
Price in USD:
8.96
Share Volume:
1.3M
Zevra Therapeutics, Inc. 52-Week Range
52-Week High:
13.16
52-Week Low:
6.19
Sell
49
Zevra Therapeutics, Inc. (ZVRA)
is a Sell
Zevra Therapeutics, Inc. Share Price Forecast
-
What is the Zevra Therapeutics, Inc. stock price today?The Zevra Therapeutics, Inc. stock price is 8.96 USD today.
-
Will ZVRA stock go up or go down?Zevra Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Zevra Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Zevra Therapeutics, Inc. is overvalued.
Is Zevra Therapeutics, Inc. Stock a Buy?
-
Zevra Therapeutics, Inc. share price is 8.96 while ZVRA 8-day exponential moving average is 8.04, which is a Buy signal.
-
The stock price of ZVRA is 8.96 while Zevra Therapeutics, Inc. 20-day EMA is 5.47, which makes it a Buy.
-
Zevra Therapeutics, Inc. 50-day exponential moving average is 2.84 while ZVRA share price is 8.96, making it a Buy technically.
-
ZVRA stock price is 8.96 and Zevra Therapeutics, Inc. 200-day simple moving average is 0.82, creating a Buy signal.
Fundamental Analysis of Zevra Therapeutics, Inc.
Is Zevra Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.54 per share, and an increase next year of $1.12 per share.
Technical Analysis of Zevra Therapeutics, Inc.
Should I short Zevra Therapeutics, Inc. stock?
-
ZVRA Moving Average Covergence Divergence (MACD) indicator is 2.43, suggesting Zevra Therapeutics, Inc. is a Buy
-
Zevra Therapeutics, Inc. Relative Strength Index (RSI) is 56.49, which suggest Zevra Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Zevra Therapeutics, Inc. is (8.25 - 8.75), which suggest Zevra Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Zevra Therapeutics, Inc. is (8.22 - 10.3), which suggest Zevra Therapeutics, Inc. is a Sell
* Zevra Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.